Search

everythinglearnresearchcommunity

for

Search:↓

Cancer treatment drugs can cause permanent hair loss by damaging hair follicle stem cells, but a specific inhibitor might reverse this effect.

No cure exists for alopecia areata, and treatments are personalized.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

Alopecia areata is hard to treat, but new targeted therapies show promise.

Cannabinoid and steroid-based drugs could be new treatments for Tourette syndrome, but more research is needed to confirm their effectiveness and safety.

Exosomal miRNA-218-5p promotes hair growth and development.

Capillary and dermal papilla interactions are vital for hair growth and aging, with potential for treating hair loss.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Trichostatin A helps restore hair-growing ability in skin cells used for hair regeneration.

Caspases do more than kill cells; they also help in cell growth and disease, and targeting them could lead to new treatments.

Accurate protein modeling can help develop new treatments for prostate cancer and other diseases.

Arg1+ macrophages may play a role in causing alopecia areata.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

TGF-β2 helps activate hair follicle stem cells by counteracting BMP signals.

Targeting blood vessels may help treat skin diseases.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Certain small molecules can promote hair growth by activating a cellular cleanup process called autophagy.

Short-chain fatty acids from *Cutibacterium acnes* cause skin inflammation, contributing to acne.

Inhibiting ODC can prevent UV-induced skin cancer.

Netherton syndrome has two subtypes with shared immune traits but different allergic and immune responses, suggesting targeted treatments.

EGFR signaling is essential for ear cell regeneration in both birds and mammals.

Emerging therapies like JAK inhibitors show promise for hair regrowth in alopecia areata.

The study found that the enzyme linked to acne is present in the same areas of both acne-affected and normal skin.

Blocking the Wnt/β‐catenin pathway can speed up wound healing, reduce scarring, and improve cartilage repair.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

New therapies for Birt–Hogg–Dubé syndrome are being developed based on understanding the FLCN gene's role.

Understanding EGFR roles could lead to new hair loss treatments.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.